Summary statement IV: Obesity and diabetes: Opportunities for translation of basic research

Vascular Pharmacology

Volumn 46, Issue 5 SPEC. ISS., 2007, Pages 324-326

  Engelgau, Michael M ^a   Vinicor, Frank ^a,b   Simionescu, Maya ^b   King, George L ^c   Meininger, Cynthia ^d   Mensah, George A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^c JOSLIN DIABETES CENTER   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Diabetes; Endothelial cells; Obesity

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I;

ARTICLE; BLOOD VESSEL WALL; CHRONIC DISEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEALTH SURVEY; HUMAN; MEDICAL RESEARCH; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 33847740678     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.10.015     Document Type: Article

References (5)

1. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 346 (2002) 392-403
2. Diabetes Prevention Program Research Group. The cost effectiveness of lifestyle intervention or metformin in prevention type 2 diabetes in person with impaired glucose tolerance. Ann. Intern. Med. 142 (2005) 323-332
3. Wang J., Armour T., Geiss L.S., and Engelgau M.M. Obesity and diabetes: dual epidemics on the rise. Curr. Opin. Endocrinol. Diabetes 12 (2005) 174-180
4. Wild, S., Roglic, G., Green, A., Sicree, R., King, H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030.
5. World Health Organization. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/ accessed 7/13/05.